SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

Syndax Pharmaceuticals Names Aaron Ondrey CFO, Goldan to Retire

Syndax will appoint Aaron A. Ondrey as CFO on November 9, 2026, succeeding Keith A. Goldan, who will retire and serve as an advisor during an interim period.

SNDX

Related stories